1. Insmed Appoints David W.J. McGirr to Its Board of Directors

    Insmed Appoints David W.J. McGirr to Its Board of Directors

    MONMOUTH JUNCTION, NJ, Nov 01, 2013 (Marketwired via COMTEX) -- Insmed IncorporatedINSM +2.51% , a biopharmaceutical company focused on developing an inhaled anti-infective to treat patients battling serious lung diseases in orphan indications that are often life-threatening, today announced the appointment of David W.J. McGirr to its Board of Directors. Mr. McGirr, former Chief Financial Officer of Cubist Pharmaceuticals, Inc. will also serve as the Chairman of Insmed's Audit Committee.

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned